Researchers to use Toshiba MRI system to study football-related brain injuries

As more research into the long-term effects of repeated head impacts as a result of playing football continues to be released, much of the focus is on studying the causes and mechanisms of the degenerative brain disease chronic traumatic encephalopathy (CTE).

Now, researchers from the University of California, Irvine are teaming up with Toshiba America Medical Systems to conduct a study investigating the presence of cerebral microbleeds in football players at the high-school level as a potential precursor for CTE.

The study will be carried out using Toshiba’s Vantage Titan 3T MR system to scan the brains of 150 volunteers—100 football players, 50 control subjects—from a local high school to assess the performance of non-contrast MRI as a safer way to examine youth athletes for early signs of CTE.

“This study presents an opportunity to determine how Toshiba’s MRI equipment can be used by healthcare providers to safely and effectively diagnose serious brain trauma or CTE earlier than ever before, which could ultimately impact a patient’s quality of life in the future,” said Eugene Mensah, PhD, director of clinical collaborations for Toshiba. “We are proud to have the researchers using Toshiba’s Vantage Titan 3T MR system to establish these potential markers of CTE, which speaks to Toshiba’s commitment to partnering with healthcare providers to identify the right imaging solutions to complex clinical situations.”

Read the full announcement here.

 

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.